Atlas Trials

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Clinical trial NCT01217697 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT01217697
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Prostate NeoplasmsGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, Male

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.